Aviron
Executive Summary
Former U.S. Bioscience CEO Boyd Clarke named president and CEO of the Mountain View, Calif.-based company. Aviron founder and CEO Leighton Read will remain chairman. Aviron's BLA filing plans for the nasal flu vaccine Flumist were delayed in November due to manufacturing difficulties (1"The Pink Sheet" Nov. 22, p. 18). U.S. Bioscience was recently acquired by MedImmune